Dr Mayra G Oberto-medina, DO | |
9055 Springbrook Dr Nw, Coon Rapids, MN 55433-5841 | |
(763) 780-9155 | |
Not Available |
Full Name | Dr Mayra G Oberto-medina |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 23 Years |
Location | 9055 Springbrook Dr Nw, Coon Rapids, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790738185 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 48504 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Memorial Health | Robbinsdale, MN | Hospital |
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Firstlight Health System | Mora, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Memorial Health Care | 0042123028 | 483 |
Novacare Outpatient Rehabilitation East Inc | 3678480290 | 617 |
News Archive
The non-O ABO blood type is the most important risk factor for venous thromboembolism (blood clots in veins), making up 20% of attributable risk for the condition, according to a new study in CMAJ (Canadian Medical Association Journal).
A fat yet muscular mouse is helping researchers learn whether more muscle improves the cardiovascular health of obese individuals. We are looking for ways to counteract the unhealthy effects of fat, said Dr. David Stepp, vascular biologist at the Medical College of Georgia Vascular Biology Center and co-director of MCG's Diabetes & Obesity Discovery Institute.
Older women with suspected ovarian cancer are often not referred for investigation as quickly as younger women, new research suggests.
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.
› Verified 9 days ago
Entity Name | Healtheast Medical Research Institute |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
The non-O ABO blood type is the most important risk factor for venous thromboembolism (blood clots in veins), making up 20% of attributable risk for the condition, according to a new study in CMAJ (Canadian Medical Association Journal).
A fat yet muscular mouse is helping researchers learn whether more muscle improves the cardiovascular health of obese individuals. We are looking for ways to counteract the unhealthy effects of fat, said Dr. David Stepp, vascular biologist at the Medical College of Georgia Vascular Biology Center and co-director of MCG's Diabetes & Obesity Discovery Institute.
Older women with suspected ovarian cancer are often not referred for investigation as quickly as younger women, new research suggests.
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.
› Verified 9 days ago
Entity Name | North Memorial Health Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851344907 PECOS PAC ID: 0042123028 Enrollment ID: O20040122000470 |
News Archive
The non-O ABO blood type is the most important risk factor for venous thromboembolism (blood clots in veins), making up 20% of attributable risk for the condition, according to a new study in CMAJ (Canadian Medical Association Journal).
A fat yet muscular mouse is helping researchers learn whether more muscle improves the cardiovascular health of obese individuals. We are looking for ways to counteract the unhealthy effects of fat, said Dr. David Stepp, vascular biologist at the Medical College of Georgia Vascular Biology Center and co-director of MCG's Diabetes & Obesity Discovery Institute.
Older women with suspected ovarian cancer are often not referred for investigation as quickly as younger women, new research suggests.
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mayra G Oberto-medina, DO 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Dr Mayra G Oberto-medina, DO 9055 Springbrook Dr Nw, Coon Rapids, MN 55433-5841 Ph: (763) 780-9155 |
News Archive
The non-O ABO blood type is the most important risk factor for venous thromboembolism (blood clots in veins), making up 20% of attributable risk for the condition, according to a new study in CMAJ (Canadian Medical Association Journal).
A fat yet muscular mouse is helping researchers learn whether more muscle improves the cardiovascular health of obese individuals. We are looking for ways to counteract the unhealthy effects of fat, said Dr. David Stepp, vascular biologist at the Medical College of Georgia Vascular Biology Center and co-director of MCG's Diabetes & Obesity Discovery Institute.
Older women with suspected ovarian cancer are often not referred for investigation as quickly as younger women, new research suggests.
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.
› Verified 9 days ago
Dr. Jaya Bhattarai, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Zongyu J Chen, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 9145 Springbrook Dr, #200, Coon Rapids, MN 55433 Phone: 612-871-1145 Fax: 612-870-5491 | |
Amber Galarowicz, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Evan L Domeyer, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Natalia Yazigi, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Linda Benjamin Soucie, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Wendoly R Slattery, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 |